Premium
Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial
Author(s) -
Merkies Ingemar S. J.,
Lawo JohnPhilip,
Edelman Jonathan M.,
De Bleecker Jan L.,
Sommer Claudia,
Robberecht Wim,
Saarela Mika,
Kamienowski Jerzy,
Stelmasiak Zbigniew,
Mielke Orell,
Tackenberg Björn,
Léger JeanMarc
Publication year - 2017
Publication title -
journal of the peripheral nervous system
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1
H-Index - 67
eISSN - 1529-8027
pISSN - 1085-9489
DOI - 10.1111/jns.12204
Subject(s) - medicine , chronic inflammatory demyelinating polyneuropathy , minimal clinically important difference , clinical trial , clinical endpoint , surrogate endpoint , adverse effect , randomized controlled trial , physical therapy , surgery , antibody , immunology